Veterinary Vaccines Market to Near US$ 18 Bn Valuation by 2030
Animals are exposed to several disease-causing threats due to various factors such as outbreak of livestock and zoonotic diseases. Veterinary vaccines are making foray into the animal healthcare industry as the most efficient approach for preventing animal-related diseases. Animal diseases are a hindrance to sustainable agricultural productivity and food security, as well as hamper economic advantages of overseas trade in livestock products. Enhanced knowledge of pathogenicity, animal immunology, and animal disease epidemiology have been on-ramp to novel animal immunization approaches. Driven by these tailwinds, the global veterinary vaccines market will register a value of nearly US$ 17 Bn by 2030 end, tracing a healthy growth path.
Report Metric s
Base year considered
Actual estimates/Historical data
2015 - 2019
2020 - 2030
Value (US$) Mn
Product, Disease, Distribution Channel, Species, and Region
North America (US & Canada), Latin America (Argentina, Brazil, Mexico, Rest of Latin America), Western Europe (UK, Germany, France, Spain, Italy, , BENELUX, NORDIC Countries and Rest of Western Europe), Eastern Europe (Russia, Poland, Rest of Eastern Europe) APEJ (Greater China, India, ASEAN, Australia and New Zealand, Rest of APEJ), Japan and MEA (GCC Countries, South Africa, Rest of MEA)
Boehringer Ingelheim GmbH. Zoetis Inc., Elanco Animal Health, Merck & Co., Inc., and major 10 players covered
Revenue forecasts, company share, competitive landscape, growth factors, regulatory scenario, and trends
Veterinary Vaccines Market - Key Research Findings
- The global veterinary vaccines market was valued at US$ 9.1 Bn in 2020, and is expected to expand at a CAGR of 7% during the forecast period of 2020-2030.
- Increasing prevalence of zoonotic diseases, rising pet ownership, and increasing government initiatives to reduce contagious disease are some of the factors driving the demand for veterinary vaccines.
- Collectively, Western Europe and North America are expected to account for more than half of the revenue share in the global veterinary vaccines market by the end of 2030.
- North America will continue to be a prominent regional market for veterinary vaccines, due to the growing frequency of drug approvals and drug innovation, and higher pet adoption rate.
- Attenuated live vaccines remain the most preferred product in the global veterinary vaccines market. Attenuated live vaccine testing accounted for the highest revenue in 2019, and the trend is projected to continue throughout the forecast period.
- Demand for attenuated live vaccines for highly contagious diseases such as foot and mouth disease is relatively high.
- In terms of species, livestock animals accounted for a major revenue share, due to the growing need for livestock animal immunization to assure the safety of food products and dairy products. Rising need for primary and secondary food items for livestock animals helps in creating sustainable demand for livestock vaccines; while rising disposable income, secluded lifestyles, and humanization of pets are driving demand for companion animal vaccines.
Key Factors Shaping Veterinary Vaccines Market
Improving Public Health by Controlling Contagious Diseases Such as Avian Influenza
Governments are adopting mass vaccination programs for animals to stop disease transmission from animals to humans. This is expected to create sustainable demand for vaccines for national stockpiles. To cite an example, in 2014, the Bangladesh government, in collaboration with the WHO, adopted a mass vaccination campaign for dogs to control rabies. The vaccination drive was included in the national plan, which aims to eliminate rabies from the country by 2020.
However, the recent coronavirus (COVID-19) pandemic has substantially hit the profit margins of players in the veterinary vaccines market. The market that ranges from livestock to companion animal healthcare, has been subject to uncertainties amidst the pandemic. Initial rumours blaming meat and meat products for the spread have resulted in temporary halts in manufacturing facilities. However, further studies have highlighted that, meat consumption does not spread the infection. This, in turn, has reignited the growth engine of the veterinary vaccines market, with demand upswing for animal-based products such as milk, eggs, and meat.
Improving Food Security Regulations Creates Strong Demand for Veterinary Vaccines
Increasing initiatives by various governments around the world to ensure food security are expected to sustainably drive the demand for veterinary vaccines. According to the Food and Agricultural Organization (FAO) of the United Nations, food production would need to increase by 70% between 2007 and 2050 to feed the global population. The global population is increasing at a yearly average rate of 3%, and is expected to reach 9.1 Bn by 2050 from 7.3 Bn in 2014. Consumption of meat and associated products is projected to reach 376 million tonnes by 2030. These factors are expected to drive the growth of the livestock segment in the global veterinary vaccines market.
Advancements in Biotechnology and Veterinary Science in Developed Economies
Greater focus on innovation to avoid zoonotic diseases coupled with advancements in biotechnology is expected to create a favourable platform for the development of veterinary vaccines in high-income countries - the U.S and U.K. These techniques include next-generation sequencing and synthetic biology and systems biology, among others. Further, sustained funding of multi-disciplinary vaccinology studies could improve vaccine development efficiency and shorten time-to-market for upcoming veterinary vaccines.
Growing Importance of Developing Protozoan Parasitic Vaccines
The veterinary healthcare industry is witnessing increased demand for protozoan parasitic vaccines from countries in tropical and sub-tropical regions. Development of resistance to various chemotherapeutic agents is contributing to increased demand for vaccines over anti-parasitic drugs. In this regard, scientists have noted that, the production of third-generation DNA veterinary vaccines against protozoan parasites could prove largely helpful. These vaccines are safe and do not contain any pathogen.
Veterinary Vaccines Market: Structure Analysis
- Vaccine development and procurement involves close partnership between industry players and research and academia, which leads to meaningful product innovation.
- For instance, in May 2016, Bayer partnered with BioNTech to develop novel mRNA vaccines and therapeutics for animal health indications.
- Prominent players continue to address the unmet needs in the market through continuous investments and clinical trials.
- The top three prominent players in the veterinary vaccines market are Boehringer Ingelheim GmbH, Zoetis, and Elanco Animal Health; they contributed around 40% of the revenue share of the total veterinary vaccines market.
Manufacturers Continue to Eye Attenuated Live VaccinesAttenuated live vaccines have been the conventional vaccination method in the field of animal healthcare, and are under experiments for developing further applications. Despite their status as traditional vaccines and associated drawbacks, attenuated live vaccines continue to maintain their primacy in the veterinary vaccines market. Moving ahead, DNA vaccines will deliver effectiveness and capability of producing response akin to attenuated live vaccines, and are relatively stable as compared to them. Over the following decade, the application of DNA vaccines in treating animal diseases will nearly double.
Developed Regions at Leading Edge; APAC to Attract Stakeholders
North America and Europe continue to shape revenue development of the global veterinary vaccines market. Uptick in usage of efficacious veterinary vaccines in tandem with tech-advanced vaccine delivery equipment to address increasing cases of canine disorders are critical in defining the veterinary vaccines market in these developed regions. Furthermore, rising ownership and adoption of companion animals along with uptight vaccination norms for these animals are adding another leg of growth to these developed regional markets. Asia Pacific (APAC) is also representing investment opportunities, underpinned by collaborative initiatives of governments and private firms to promote better animal healthcare. In addition, livestock and companion animal owners in the region are showing interest in following regular vaccination.
Protozoan Parasitic Vaccines to Mold Future LandscapeIncreasing resistance of certain parasites to anti-parasitic drugs and absence of effective parasite vaccines are an existing concern in the veterinary healthcare industry, especially in tropical and sub-tropical regions. This demanding situation is paving the way for protozoan parasitic vaccines. Backed by continuous research, scientists have unleashed the potential of these third-generation DNA vaccines against protozoan parasites. Further, these protozoan parasitic vaccines are cost-effective, relatively stable as compared to attenuated live veterinary vaccines, and considerably safe due to the absence of pathogens.
Attenuated live vaccines capture prominent revenue share
Inactivated vaccines to see substantial returns
High adoption in treating anaplasmosis
Adoption in treating foot & mouth diseases on rise
Veterinary clinics account for greater sales
Sales via veterinary hospitals to decline
High demand for livestock animal veterinary vaccines
Companion animal veterinary vaccines to slide
How Growth will Unfold
Driven by increasing reliance on livestock animals for various purposes, including eggs, meat, and other animal-based products, manufacturers are laying greater focus on developing livestock veterinary vaccines. In addition, governments across the world are imposing bans on the usage of antibiotics on livestock animals meant for food. Consequently, animal meat producers are shifting towards regular vaccination to avoid the use of non-essential veterinary drugs. Market players are also developing companion animal vaccines, owing to rising pet animal ownership across the world, and elevating trend of animal adoption backed by several non-governmental organizations (NGOs).
* This data is only a representation. Actual data may vary and will be available in report.Click Here To Know How The Growth Will Unfold
Custom Market Research Services
FMI offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.
A recent market study published by Future Market Insights (FMI) on the veterinary vaccines market includes global industry analysis of 2015-2019 and opportunity assessment for 2020-2030, and delivers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical as well as current growth parameters of the veterinary vaccines market, growth prospects are obtained with maximum precision.
Veterinary Vaccines Market Taxonomy
The global veterinary vaccines is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
- Attenuated Live Vaccines
- Conjugate Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- Toxoid Vaccines
- DNA Vaccines
- Recombinant Vaccines
- Canine Parvovirus
- Foot & Mouth Disease
- New Castle Disease
- Distemper Disease
- Porcine Reproductive & Respiratory Syndrome (PRRS)
- Veterinary Clinics
- Veterinary Hospitals
- Veterinary Research Institutes
- Retail Pharmacies
- Companion Animals
- Livestock Animals
- North America
- Latin America
- Western Europe
- Eastern Europe
- Asia Pacific Excluding Japan (APEJ)
- Middle East & Africa (MEA)
The report initiates with the executive summary of the veterinary vaccines market, which includes a summary of key findings and statistics of the market. It also includes market size and revenue distribution of market segment of the veterinary vaccines market.
Readers can find the definition and a detailed segmentation of the veterinary vaccines market in this chapter, which will help them understand the basic information about the market.
This section includes key product development trend and innovative market expansion strategies.
This section includes premium insights such as key promotional strategies, regulations, reimbursement and many more. This section helps readers understand the key factors associated with the veterinary vaccines market.
This chapter explains the key macroeconomic factors, drivers, restraints, trends and opportunity analysis that are expected to influence growth of the veterinary vaccines market over the forecast period. Moreover, in-depth information about the market dynamics and their impact analysis on the market have been provided in the successive section.
This section explains the global market value analysis and forecast for the veterinary vaccines during the forecast period. This chapter includes a detailed analysis of the historical veterinary vaccines market, along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2019), and an incremental $ opportunity for the forecast period (2019-2029).
Based on product, the veterinary vaccines market is segmented attenuated live vaccines, conjugate vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, DNA vaccines, and recombinant vaccines. In this chapter, readers can find information about the key trends and developments in veterinary vaccines and market attractiveness analysis based on product.
This chapter provides details about the veterinary vaccines based on disease, and has been classified into anaplasmosis, canine parvovirus, foot & mouth disease, new castle disease, distemper disease, influenza, porcine reproductive & respiratory syndrome (PRRS), others. In this chapter, readers can understand the market attractiveness analysis based on disease.
This chapter provides details about the veterinary vaccines based on distribution channel, and has been classified into veterinary clinics, veterinary hospitals, veterinary research institutes, and retail pharmacies. In this chapter, readers can understand the market attractiveness analysis based on distribution channel.
This chapter provides details about the veterinary vaccines market based on species, and has been classified into companion animals, livestock animals, and equine. In this chapter, readers can understand the market attractiveness analysis based on species.
This chapter explains how the Veterinary Vaccines market will grow across various geographic regions such as North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan, and Middle East & Africa (MEA).
This chapter includes a detailed analysis of growth of the North America veterinary vaccines market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the regional trends, and market growth based on the product type and countries in North America.
This chapter provides the growth scenario of the veterinary vaccines market in Latin American countries such as Argentina, Brazil, Mexico, and the Rest of Latin America. Along with this, assessment of the market across target segments has been provided.
This chapter provides the growth scenario of the veterinary vaccines market in Western Europe in several countries such as Germany, the U.K., France, Spain, Italy, BENELUX and the Rest of Western Europe are included in this chapter.
This chapter provides the growth scenario of the Veterinary Vaccines market in Eastern Europe in several countries such as Russia, Poland, Rest of Eastern Europe are included in this chapter.
This chapter highlights the growth of the veterinary vaccines in Asia Pacific Excluding Japan (APEJ) by focusing on Greater China, India, ASEAN, Australia & New Zealand, and Rest of APEJ. This section also help readers understand the key factors that are responsible for the growth of the veterinary vaccines market in Asia Pacific Excluding Japan (APEJ).
This chapter highlights the growth of the veterinary vaccines in Japan. This section also help readers understand the key factors that are responsible for the growth of the veterinary vaccines market in Japan.
This chapter provides information about how the veterinary vaccines market will grow in major countries in the MEA region such as GCC Countries, South Africa, and the Rest of MEA, during the forecast period.
In this chapter, readers can find detailed company share analysis, and tier structure analysis.
In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the veterinary vaccines market, along with a detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Boehringer Ingelheim GmbH. Zoetis Inc., Elanco Animal Health.
This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the veterinary vaccines report.
This chapter help readers understand the research methodology followed to obtain various conclusions as well as important qualitative and quantitative information about the veterinary vaccines market.
How the research was conducted?
- Marketing Directors
- Product Managers
- Business Development Officers
- Production Managers
- Sales Executives
- Industry Experts
- Current Market Dynamics and Challenges
- Yesteryear Trends
- Market Characteristics
- Market Performance and Growth Quadrants
- Strategic Growth Initiatives
- Near-term and long-Term Market Growth Prospects
- Market Segment Splits and Authenticity
- Opinions on Market Projections and Validity of Assumptions
- World Health Organization
- American Society for the Prevention of Cruelty to Animal
- Small Animal Veterinary Association (WSAVA).
- World Organisation for Animal Health
- Company Press Releases
- Annual Reports and Investor Presentations
- Research Papers
- Government Websites and Publications
Primary Interview Splits